Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1042 gün önce
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

Etiketler: HOTH
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 786 gün önce
Japan Services PMI Eases To 53.1 In October - Jibun

Japan Services PMI Eases To 53.1 In October - Jibun

The services sector in Japan continued to expand in October, albeit at a slightly slower pace, the latest survey from Jibun Bank revealed on Thursday with a services PMI score of 53.1.
RTTNews | 1s 8 dakika önce
Taiwan Bourse Due For Support On Thursday

Taiwan Bourse Due For Support On Thursday

The Taiwan stock market has finished lower in back-to-back sessions, stumbling more than 640 points or 2.3 percent in that span. The Taiwan Stock Exchange now sits just beneath the 27,720-point plateau although it may stop the bleeding on Thursday.
RTTNews | 1s 13 dakika önce
Singapore Shares May Find Traction On Thursday

Singapore Shares May Find Traction On Thursday

The Singapore stock market has moved lower in two straight sessions, slumping more than 25 points or 0.6 percent along the way. The Straits Times Index now sits just beneath the 4,420-point plateau although it may find support on Thursday.
RTTNews | 1s 43 dakika önce
Rebound Anticipated For Malaysia Stock Market

Rebound Anticipated For Malaysia Stock Market

The Malaysia stock market on Wednesday snapped the two-day winning streak in which it had collected almost 15 points or 0.9 percent. The Kuala Lumpur Composite Index now sits just above the 1,620-point plateau although it figures to bounce higher again on Thursday.
RTTNews | 2s 13 dakika önce